Showing results (61-70 of 142) with videos related to

Sort By:
Pageof 15
Molecular Therapy. Nucleic Acids|September 18, 2017
Human DMBT1-Derived Cell-Penetrating Peptides for Intracellular siRNA DeliveryMartina Tuttolomondo, Cinzia Casella, Pernille Lund Hansen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 18, 2013
Anti-human CD73 monoclonal antibody inhibits metastasis formation in human breast cancer by inducing clustering and internalization of CD73 expressed on the surface of cancer cellsMikkel G Terp, Kristina A Olesen, Eva C Arnspang, et al.
BMC Systems Biology|August 20, 2014
KeyPathwayMiner 4.0: condition-specific pathway analysis by combining multiple omics studies and networks with CytoscapeNicolas Alcaraz, Josch Pauling, Richa Batra, et al.
Cell Death & Disease|February 9, 2020
Replication and ribosomal stress induced by targeting pyrimidine synthesis and cellular checkpoints suppress p53-deficient tumorsSona Hubackova, Eliska Davidova, Stepana Boukalova, et al.
International Journal of Cancer|August 16, 2018
CYPOR is a novel and independent prognostic biomarker of recurrence-free survival in triple-negative breast cancer patientsMartin H Pedersen, Brian L Hood, Sidse Ehmsen, et al.
British Journal of Haematology|February 26, 2013
Hepatocyte growth factor pathway upregulation in the bone marrow microenvironment in multiple myeloma is associated with lytic bone diseaseIda B Kristensen, Jacob H Christensen, Maria B Lyng, et al.
Life Sciences|March 31, 2021
MiR-142-3p targets HMGA2 and suppresses breast cancer malignancyBehzad Mansoori, Pascal H G Duijf, Ali Mohammadi, et al.
Molecular Biosystems|February 28, 2015
Selection of LNA-containing DNA aptamers against recombinant human CD73Ida C Elle, Kasper K Karlsen, Mikkel G Terp, et al.
Breast Cancer Research and Treatment|November 21, 2015
Gene expression alterations associated with outcome in aromatase inhibitor-treated ER+ early-stage breast cancer patientsKarina G Thomsen, Maria B Lyng, Daniel Elias, et al.
Pageof 15